Osaka, Japan

Ohe Osamu


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1983-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ohe Osamu: Innovator in Pharmaceutical Chemistry

Introduction

Ohe Osamu is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex problems in medicine.

Latest Patents

Ohe Osamu holds 2 patents related to 1,4-naphthoquinone derivatives. His latest patents include "1,4-Napthoquinone derivatives and use thereof," which describes compounds represented by a specific general formula. These compounds exhibit anticoccidium activity and can be synthesized or partially cultivated from Streptomyces auranticolor. Another patent focuses on the use of 1,4-naphtoquinone derivatives in treating coccidiosis, highlighting their potential in addressing this significant health issue.

Career Highlights

Ohe Osamu is affiliated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing research and development efforts. His innovative work has contributed to the company's reputation as a leader in pharmaceutical solutions.

Collaborations

Throughout his career, Ohe Osamu has collaborated with esteemed colleagues, including Koichi Ikushima and Hirokazu Tanaka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Ohe Osamu's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a key innovator in the field. His work continues to impact the development of effective treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…